Article
ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date
28 Jan 2022
Abstract excerpt
The ROS-1 gene plays a major role in the oncogenesis of numerous tumors. ROS-1 rearrangement is found in 0.9–2.6% of non-small-cell lung cancers (NSCLCs), mostly lung adenocarcinomas, with a significantly higher rate of women, non-smokers, and a tendency to a younger age. It has been demonstrated that ROS-1 is a true oncogenic driver, and tyrosine kinase inhibitors (TKIs) targeting ROS-1 can block tumor growth...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
